Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: A4HFP2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 199 | 203 | PF00656 | 0.759 |
CLV_NRD_NRD_1 | 104 | 106 | PF00675 | 0.621 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.652 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.611 |
CLV_PCSK_SKI1_1 | 162 | 166 | PF00082 | 0.763 |
CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.700 |
CLV_PCSK_SKI1_1 | 45 | 49 | PF00082 | 0.593 |
DEG_APCC_DBOX_1 | 161 | 169 | PF00400 | 0.767 |
DEG_SPOP_SBC_1 | 175 | 179 | PF00917 | 0.657 |
DEG_SPOP_SBC_1 | 50 | 54 | PF00917 | 0.558 |
DOC_ANK_TNKS_1 | 191 | 198 | PF00023 | 0.544 |
DOC_CYCLIN_RxL_1 | 40 | 53 | PF00134 | 0.536 |
DOC_MAPK_gen_1 | 105 | 115 | PF00069 | 0.587 |
DOC_MAPK_MEF2A_6 | 106 | 115 | PF00069 | 0.580 |
DOC_MAPK_MEF2A_6 | 27 | 36 | PF00069 | 0.680 |
DOC_PP1_RVXF_1 | 107 | 113 | PF00149 | 0.587 |
DOC_PP2B_LxvP_1 | 36 | 39 | PF13499 | 0.682 |
DOC_USP7_MATH_1 | 50 | 54 | PF00917 | 0.585 |
DOC_USP7_MATH_1 | 66 | 70 | PF00917 | 0.722 |
DOC_USP7_MATH_1 | 78 | 82 | PF00917 | 0.567 |
DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.708 |
DOC_USP7_UBL2_3 | 7 | 11 | PF12436 | 0.657 |
DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.590 |
DOC_WW_Pin1_4 | 85 | 90 | PF00397 | 0.688 |
LIG_14-3-3_CanoR_1 | 176 | 182 | PF00244 | 0.722 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.671 |
LIG_FHA_1 | 176 | 182 | PF00498 | 0.638 |
LIG_LIR_Apic_2 | 20 | 26 | PF02991 | 0.614 |
LIG_LIR_Gen_1 | 91 | 101 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 91 | 97 | PF02991 | 0.509 |
LIG_SH2_STAP1 | 171 | 175 | PF00017 | 0.688 |
LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.690 |
LIG_SH3_3 | 210 | 216 | PF00018 | 0.651 |
LIG_SH3_3 | 98 | 104 | PF00018 | 0.647 |
LIG_SUMO_SIM_anti_2 | 117 | 123 | PF11976 | 0.574 |
LIG_SUMO_SIM_par_1 | 117 | 123 | PF11976 | 0.574 |
LIG_TRAF2_1 | 235 | 238 | PF00917 | 0.636 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.761 |
MOD_CK1_1 | 61 | 67 | PF00069 | 0.685 |
MOD_CK1_1 | 88 | 94 | PF00069 | 0.717 |
MOD_CK2_1 | 203 | 209 | PF00069 | 0.757 |
MOD_CK2_1 | 232 | 238 | PF00069 | 0.635 |
MOD_Cter_Amidation | 4 | 7 | PF01082 | 0.656 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.653 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.648 |
MOD_GlcNHglycan | 188 | 191 | PF01048 | 0.706 |
MOD_GlcNHglycan | 19 | 23 | PF01048 | 0.573 |
MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.663 |
MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.724 |
MOD_GSK3_1 | 124 | 131 | PF00069 | 0.689 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.656 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.603 |
MOD_N-GLC_1 | 83 | 88 | PF02516 | 0.772 |
MOD_NEK2_1 | 18 | 23 | PF00069 | 0.652 |
MOD_NEK2_1 | 49 | 54 | PF00069 | 0.488 |
MOD_NEK2_2 | 124 | 129 | PF00069 | 0.611 |
MOD_PIKK_1 | 11 | 17 | PF00454 | 0.753 |
MOD_PKA_2 | 175 | 181 | PF00069 | 0.719 |
MOD_Plk_1 | 61 | 67 | PF00069 | 0.696 |
MOD_Plk_2-3 | 196 | 202 | PF00069 | 0.553 |
MOD_Plk_4 | 177 | 183 | PF00069 | 0.636 |
MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.590 |
MOD_ProDKin_1 | 85 | 91 | PF00069 | 0.686 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6I4 | Leptomonas seymouri | 58% | 97% |
A0A3Q8IEC6 | Leishmania donovani | 80% | 100% |
A0A3R7MDN0 | Trypanosoma rangeli | 43% | 100% |
A4I2R8 | Leishmania infantum | 80% | 100% |
D0A5X3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
E9AD95 | Leishmania major | 82% | 100% |
E9AZ20 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
V5B8N2 | Trypanosoma cruzi | 43% | 100% |